HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M500424-JLR200v1 47/1/67    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, L. Articles by Olofsson, S.-O. Search for Related Content PubMed PubMed Citation Articles by Li, L. Articles by Olofsson, S.-O. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 47, 67-77, January 2006
Copyright © 2006 by American Society for Biochemistry and Molecular Biology

Epigallocatechin gallate increases the formation of cytosolic lipid droplets and decreases the secretion of apoB-100 VLDL

Lu Li¹, Pia Stillemark-Billton¹, Caroline Beck¹, Pontus Boström¹, Linda Andersson, Mikael Rutberg, Johanna Ericsson, Björn Magnusson, Denis Marchesan, Anna Ljungberg, Jan Borén and Sven-Olof Olofsson²

Wallenberg Laboratory for Cardiovascular Research, Göteborg University, Sahlgrenska University Hospital, SE-413 45 Göteborg, Sweden

Published, JLR Papers in Press, October 14, 2005.

¹ L. Li, P. Stillemark-Billton, C. Beck, and P. Boström contributed equally to this work.

² To whom correspondence should be addressed. e-mail: sven-olof.olofsson{at}wlab.gu.se

Epigallocatechin gallate (EGCG) increases the formation of cytosolic lipid droplets by a mechanism that is independent of the rate of triglyceride biosynthesis and involves an enhanced fusion between lipid droplets, a process that is crucial for their growth in size. EGCG treatment reduced the secretion of both triglycerides and apolipoprotein B-100 (apoB-100) VLDLs but not of transferrin, albumin, or total proteins, indicating that EGCG diverts triglycerides from VLDL assembly to storage in the cytosol. This is further supported by the observed increase in both intracellular degradation of apoB-100 and ubiquitination of the protein (indicative of increased proteasomal degradation) in EGCG-treated cells. EGCG did not interfere with the microsomal triglyceride transfer protein, and the effect of EGCG on the secretion of VLDLs was found to be independent of the LDL receptor. Thus, our results indicate that EGCG promotes the accumulation of triglycerides in cytosolic lipid droplets, thereby diverting lipids from the assembly of VLDL to storage in the cytosol. Our results also indicate that the accumulation of lipids in the cytosol is not always associated with increased secretion of VLDL.

Supplementary key words intracellular degradation • ubiquitination • low density lipoprotein receptor • apolipoprotein B-100

Abbreviations: apoB-100, apolipoprotein B-100; EGCG, epigallocatechin gallate; GFP, green fluorescent protein; HAT, histidine affinity tag; LDLR, low density lipoprotein receptor; MTP, microsomal triglyceride transfer protein; PA, phosphatidic acid; PLD, phospholipase D

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. Yan, M. Lehto, L. Rasilainen, J. Metso, C. Ehnholm, S. Yla-Herttuala, M. Jauhiainen, and V. M. Olkkonen Oxysterol Binding Protein Induces Upregulation of SREBP-1c and Enhances Hepatic Lipogenesis Arterioscler Thromb Vasc Biol, May 1, 2007; 27(5): 1108 - 1114. [Abstract] [Full Text] [PDF]